[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20013384L - Imidazo[4,5-c]pyridin-4-on-derivater - Google Patents

Imidazo[4,5-c]pyridin-4-on-derivater

Info

Publication number
NO20013384L
NO20013384L NO20013384A NO20013384A NO20013384L NO 20013384 L NO20013384 L NO 20013384L NO 20013384 A NO20013384 A NO 20013384A NO 20013384 A NO20013384 A NO 20013384A NO 20013384 L NO20013384 L NO 20013384L
Authority
NO
Norway
Prior art keywords
imidazo
pyridine
derivatives
prophylaxis
inhibitors
Prior art date
Application number
NO20013384A
Other languages
English (en)
Other versions
NO20013384D0 (no
Inventor
Werner Mederski
Horst Juraszyk
Hanns Wurziger
Christos Tsaklakidis
Dieter Dorsch
Sabine Bernotat-Danielowski
Guido Melzer
Soheila Anzali
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20013384L publication Critical patent/NO20013384L/no
Publication of NO20013384D0 publication Critical patent/NO20013384D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Nye forbindelser med formel (I) hvor R, R1, R2, RJ og n har de i krav l angitte betydninger, er inhibitorer for koagulasjonsfaktor Xa og kan anven- des til profylakse og/eller behandling av tromboemboliske sykdommer.
NO20013384A 1999-01-08 2001-07-06 Imidazo[4,5-c]pyridin-4-on-derivater NO20013384D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900471A DE19900471A1 (de) 1999-01-08 1999-01-08 Imidazo[4,5c]-pyridin-4-on-derivate
PCT/EP1999/010236 WO2000040583A2 (de) 1999-01-08 1999-12-21 Imidazo[4,5-c]-pyridin-4-on-derivate

Publications (2)

Publication Number Publication Date
NO20013384L true NO20013384L (no) 2001-07-06
NO20013384D0 NO20013384D0 (no) 2001-07-06

Family

ID=7893790

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013384A NO20013384D0 (no) 1999-01-08 2001-07-06 Imidazo[4,5-c]pyridin-4-on-derivater

Country Status (16)

Country Link
EP (1) EP1149099A2 (no)
JP (1) JP2002534429A (no)
KR (1) KR20010086085A (no)
CN (1) CN1333772A (no)
AR (1) AR022220A1 (no)
AU (1) AU3041700A (no)
BR (1) BR9916774A (no)
CA (1) CA2357771A1 (no)
CZ (1) CZ20012407A3 (no)
DE (1) DE19900471A1 (no)
HU (1) HUP0105054A3 (no)
NO (1) NO20013384D0 (no)
PL (1) PL349341A1 (no)
SK (1) SK9442001A3 (no)
WO (1) WO2000040583A2 (no)
ZA (1) ZA200106454B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100628407B1 (ko) 1998-12-23 2006-09-26 브리스톨-마이어스 스퀴브 파마 컴파니 Ｘａ 인자 억제제로서의 질소 함유 헤테로비시클릭 화합물
BR0112292A (pt) 2000-06-23 2003-06-24 Bristol Myers Squibb Pharma Co Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto
US6878710B2 (en) 2001-05-22 2005-04-12 Bristol-Myers Squibb Pharma Company Bicyclic inhibitors of factor Xa
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
GB0225399D0 (en) * 2002-10-31 2002-12-11 Merck Sharp & Dohme Therapeutic agents
ES2543588T3 (es) 2002-12-03 2015-08-20 Pharmacyclics Llc Derivados de 2-(2-hidroxibifenil-3-il)-1H-benzoimidazol-5-carboxamidina como inhibidores del factor VIIa
DK1706403T3 (da) 2003-12-22 2012-04-23 Leuven K U Res & Dev Imidazo[4,5-c]pyridinforbindelser og fremgangsmåder til antiviral behandling
AU2005319167B2 (en) 2004-12-21 2011-09-29 Gilead Sciences, Inc. Imidazo[4,5-C]pyridine compound and method of antiviral treatment
CN101223167B (zh) 2005-07-15 2011-08-31 弗·哈夫曼-拉罗切有限公司 杂芳基稠合的环状胺
ME02005B (me) 2005-09-14 2012-08-31 Takeda Pharmaceuticals Co Inhibitori dipeptidil peptidaze za lečenje dijabetesa
WO2007035629A2 (en) 2005-09-16 2007-03-29 Takeda Pharmaceutical Company Limited Process for the preparation of pyrimidinedione derivatives
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
MX2009000235A (es) 2006-07-07 2009-01-23 Gilead Sciences Inc Compuesto de piridazina novedoso y uso del mismo.
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
JP6689821B2 (ja) * 2014-08-12 2020-04-28 シンジェンタ パーティシペーションズ アーゲー 硫黄含有置換基を有する殺有害生物的に活性な複素環式誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW219935B (no) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
EP1039907A4 (en) * 1997-12-01 2001-09-19 Merck & Co Inc THROMBIN INHIBITORS

Also Published As

Publication number Publication date
DE19900471A1 (de) 2000-07-13
CN1333772A (zh) 2002-01-30
BR9916774A (pt) 2001-10-30
ZA200106454B (en) 2002-11-06
KR20010086085A (ko) 2001-09-07
CA2357771A1 (en) 2000-07-13
HUP0105054A3 (en) 2002-12-28
WO2000040583A2 (de) 2000-07-13
EP1149099A2 (de) 2001-10-31
AU3041700A (en) 2000-07-24
HUP0105054A2 (hu) 2002-05-29
CZ20012407A3 (cs) 2001-12-12
WO2000040583A3 (de) 2000-09-21
SK9442001A3 (en) 2002-05-09
NO20013384D0 (no) 2001-07-06
PL349341A1 (en) 2002-07-15
AR022220A1 (es) 2002-09-04
JP2002534429A (ja) 2002-10-15

Similar Documents

Publication Publication Date Title
NO20002958L (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
NO20013384L (no) Imidazo[4,5-c]pyridin-4-on-derivater
NO20056030L (no) Nye pyridopyraziner og anvendelse derav som kinaseinhibitorer
RS105204A (en) Substituted 3-amino-thieno/2,3-b/pyridine- 2-carboxylic acid amide compounds and processes for preparing and their uses
ZA200306419B (en) Phenyl derivatives.
TR200101903T2 (tr) Yeni malonik asit türevleri, bunların preparasyon işlemleri.
MXPA05013536A (es) Derivados de etinilprolina.
PT752987E (pt) Derivados de pirimidinilo como inibidores da interleucina
MY130736A (en) Imidazo(4,5-c) pyridin-4-one derivatives
NO20060670L (no) N3-substituerte imidazopyridin C-kit inhibitorer
NO992770L (no) Nye heterocyklisk substituerte benzamider og deres anvendelse ved bekjempelse av sykdommer
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
ATE384722T1 (de) Alkoxypyridinderivate
NO971625L (no) Nye peptider med immunomodulatoriske effekter
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
WO2004002477A8 (de) 2-(phenyl)-2h-pyrazol-3-carbonsäure-n-4-(thioxo-heterocyclyl)-phenyl-amid derivate und entsprechende imino-heterocyclyl derivate sowie verwandte verbindungen als inhibitoren der koagulationsfaktoren xa und/oder viia zur behandlung bon thrombosen
LU83820A1 (fr) Derives de la 2-oxoazetidine,leur preparation et leur utilisation
ATE399786T1 (de) 3-substituierte 3,4-dihydro-thieno 2,3-d pyrimidin-4-one-derivate, ihre herstellung und verwendung
NO20014234L (no) Pyrazol-3-on-derivater som faktor-Xa-inhibitorer
NO20005435L (no) Bifenylderivater
ATE263166T1 (de) Neue benzoxazole mit pde-hemmender wirkung
MXPA04004307A (es) Derivados de fenoxi-n-`4-(1,1-dioxoisotiazolidin-2-il)fenil-valeramida y otros compuestos como inhibidores del factor de coagulacion xa para el tratamiento de enfermedades tromboembolicas y tumores.
ATE381568T1 (de) Pyrano(2,3-c)imidazo(1,2-a)pyridin-derivate zur behandlung von gastrointestinalen erkrankungen
MXPA04001121A (es) Derivados de fenilo.
WO2002074735A3 (de) Biurethanderivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application